Combined fibrinogen and neutrophil–lymphocyte ratio as a predictive factor in resectable colorectal adenocarcinoma

References

• SiegelRLMillerKDFedewaSAColorectal cancer statistics, 2017CA Cancer J Clin201767317719328248415
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• JonkerDJSpithoffKMarounJAdjuvant systemic chemotherapy for stage II and III colon cancer after complete resection: an updated practice guidelineClin Oncol2011235314322
   Web of Science ®Google Scholar
• VerdecchiaAFrancisciSBrennerHRecent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 dataLancet Oncol20078978479617714993
   PubMed Web of Science ®Google Scholar
• LinJQiuMXuRDobsASComparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results (SEER) databaseOncotarget2015632339353394326375551
   PubMedGoogle Scholar
• DiakosCICharlesKAMcmillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50325281468
   PubMed Web of Science ®Google Scholar
• CruszSMBalkwillFRInflammation and cancer: advances and new agentsNat Rev Clin Oncol2015121058459626122183
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• LiYJiaHYuWNomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resectionInt J Cancer2016139122023126933932
   PubMed Web of Science ®Google Scholar
• ChoIRParkJCParkCHPre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancerGastric Cancer201417470371024442663
   PubMed Web of Science ®Google Scholar
• McnamaraMGTempletonAJMagantiMNeutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancerEur J Cancer20145091581158924630393
   PubMed Web of Science ®Google Scholar
• ZouZYLiuHLNingNLiSYDuXHLiRClinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancerOncol Lett20161132241224826998156
   PubMed Web of Science ®Google Scholar
• YouJZhuGQXieLPreoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancerOncotarget2016718255162552727027440
   PubMedGoogle Scholar
• FengZWenHBiRDuanYYangWWuXThrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patientsBMC Cancer2016164326817451
   PubMed Web of Science ®Google Scholar
• TanakaNKikuchiEMatsumotoKPrognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinomaBJU Int2013111685786422757942
   PubMed Web of Science ®Google Scholar
• LuoYKimHSKimMLeeMSongYSElevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysisJ Gynecol Oncol2017283e3628382799
   PubMed Web of Science ®Google Scholar
• McmillanDCThe systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancerCancer Treat Rev201339553454022995477
   PubMed Web of Science ®Google Scholar
• LiuYHeXPanJChenSWangLPrognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studiesSci Rep201771614428733646
   PubMedGoogle Scholar
• ForrestLMMcmillanDCMcardleCSAngersonWJDunlopDJEvaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancerBr J Cancer20038961028103012966420
   PubMed Web of Science ®Google Scholar
• ZhangCXWangSYChenSQYangSLWanLXiongBAssociation between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysisOnco Targets Ther201693883389127390529
   PubMed Web of Science ®Google Scholar
• ChenJHZhaiETYuanYJSystemic immune-inflammation index for predicting prognosis of colorectal cancerWorld J Gastroenterol201723346261627228974892
   PubMed Web of Science ®Google Scholar
• HuBYangXRXuYSystemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinomaClin Cancer Res201420236212622225271081
   PubMed Web of Science ®Google Scholar
• WangHZhaoJZhangMHanLWangMXingdeLThe combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancerJ Cell Physiol201823354216422429057536
   PubMed Web of Science ®Google Scholar
• KijimaTArigamiTUchikadoYCombined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinomaCancer Sci2017108219319927889946
   PubMed Web of Science ®Google Scholar
• ArigamiTUenosonoYIshigamiSA novel scoring system based on fibrinogen and the neutrophil-lymphocyte ratio as a predictor of chemotherapy response and prognosis in patients with advanced gastric cancerOncology201690418619226981856
   PubMed Web of Science ®Google Scholar
• EdgeSBComptonCCThe American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNMAnn Surg Oncol20101761471147420180029
   PubMed Web of Science ®Google Scholar
• WestNRMccuaigSFranchiniFPowrieFEmerging cytokine networks in colorectal cancerNat Rev Immunol2015151061562926358393
   PubMed Web of Science ®Google Scholar
• ShalapourSKarinMImmunity, inflammation, and cancer: an eternal fight between good and evilJ Clin Invest201512593347335526325032
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
   PubMed Web of Science ®Google Scholar
• BalkwillFRThe chemokine system and cancerJ Pathol2012226214815721989643
   PubMed Web of Science ®Google Scholar
• PineJKMorrisEHutchinsGGSystemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumourBr J Cancer2015113220421126125452
   PubMed Web of Science ®Google Scholar
• YingHQDengQWHeBSThe prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patientsMed Oncol2014311230525355641
   PubMed Web of Science ®Google Scholar
• LinMSHuangJXYuHPrognostic significance of Glasgow prognostic score in patients with stage II colorectal cancerInt J Clin Exp Med2015810191381914326770545
   PubMed Web of Science ®Google Scholar
• ShibutaniMMaedaKNagaharaHIsekiYIkeyaTHirakawaKPrognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancerOncol Lett20171321000100628356991
   PubMed Web of Science ®Google Scholar
• ShibutaniMMaedaKNagaharaHPrognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancerWorld J Gastroenterol201521349966997326379401
   PubMed Web of Science ®Google Scholar
• MosesKBrandauSHuman neutrophils: Their role in cancer and relation to myeloid-derived suppressor cellsSemin Immunol201628218719627067179
   PubMed Web of Science ®Google Scholar
• FelixKGaidaMMNeutrophil-derived proteases in the microenvironment of pancreatic cancer-active players in tumor progressionInt J Biol Sci201612330231326929737
   PubMed Web of Science ®Google Scholar
• TerzićJGrivennikovSKarinEKarinMInflammation and colon cancerGastroenterology201013862101211420420949
   PubMed Web of Science ®Google Scholar
• LinEYPollardJWRole of infiltrated leucocytes in tumour growth and spreadBr J Cancer200490112053205815164120
   PubMed Web of Science ®Google Scholar
• HoffmannTKDworackiGTsukihiroTSpontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importanceClin Cancer Res2002882553256212171883
   PubMed Web of Science ®Google Scholar
• CézéNThibaultGGoujonGPre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapyCancer Chemother Pharmacol20116851305131321448592
   PubMed Web of Science ®Google Scholar
• QiuJYuYFuYYeFXieXLuWPreoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancerJ Obstet Gynaecol Res201238465165722413879
   PubMed Web of Science ®Google Scholar
• LuKZhuYShengLLiuLShenLWeiQSerum fibrinogen level predicts the therapeutic response and prognosis in patients with locally advanced rectal cancerHepatogastroenterology201158110–1111507151021940318
   PubMedGoogle Scholar
• PalumboJSTalmageKEMassariJVPlatelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cellsBlood2005105117818515367435
   PubMed Web of Science ®Google Scholar